These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7610054)

  • 1. Improved accumulation and activity of ribozymes expressed from a tRNA-based RNA polymerase III promoter.
    Thompson JD; Ayers DF; Malmstrom TA; McKenzie TL; Ganousis L; Chowrira BM; Couture L; Stinchcomb DT
    Nucleic Acids Res; 1995 Jun; 23(12):2259-68. PubMed ID: 7610054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retroviral vectors designed for targeted expression of RNA polymerase III-driven transcripts: a comparative study.
    Ilves H; Barske C; Junker U; Böhnlein E; Veres G
    Gene; 1996 Jun; 171(2):203-8. PubMed ID: 8666273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling their intracellular localization.
    Bertrand E; Castanotto D; Zhou C; Carbonnelle C; Lee NS; Good P; Chatterjee S; Grange T; Pictet R; Kohn D; Engelke D; Rossi JJ
    RNA; 1997 Jan; 3(1):75-88. PubMed ID: 8990401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a nonviral vector to express a chimeric tRNA-ribozyme against lymphocytic choriomeningitis virus: cytoplasmic accumulation of a catalytically competent transcript but minimal antiviral effect.
    Gebhard JR; Perry CM; Mahadeviah S; Whitton JL
    Antisense Nucleic Acid Drug Dev; 1997 Feb; 7(1):3-11. PubMed ID: 9055033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significantly higher activity of a cytoplasmic hammerhead ribozyme than a corresponding nuclear counterpart: engineered tRNAs with an extended 3' end can be exported efficiently and specifically to the cytoplasm in mammalian cells.
    Kuwabara T; Warashina M; Koseki S; Sano M; Ohkawa J; Nakayama K; Taira K
    Nucleic Acids Res; 2001 Jul; 29(13):2780-8. PubMed ID: 11433023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligonucleotide scanning of native mRNAs in extracts predicts intracellular ribozyme efficiency: ribozyme-mediated reduction of the murine DNA methyltransferase.
    Scherr M; Reed M; Huang CF; Riggs AD; Rossi JJ
    Mol Ther; 2000 Jul; 2(1):26-38. PubMed ID: 10899825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA-polymerase III-driven expression cassettes in human gene therapy.
    Medina MF; Joshi S
    Curr Opin Mol Ther; 1999 Oct; 1(5):580-94. PubMed ID: 11249665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of the CCR5 beta-chemokine receptor and inhibition of HIV-1 infection by stable VA1-ribozyme chimeric transcripts.
    Cagnon L; Rossi JJ
    Antisense Nucleic Acid Drug Dev; 2000 Aug; 10(4):251-61. PubMed ID: 10984119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrovirus-mediated transfer of anti-MDR1 hammerhead ribozymes into multidrug-resistant human leukemia cells: screening for effective target sites.
    Kobayashi H; Takemura Y; Wang FS; Oka T; Ohnuma T
    Int J Cancer; 1999 Jun; 81(6):944-50. PubMed ID: 10362143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of siRNA from a single transcript that includes multiple ribozymes in mammalian cells.
    Kato Y; Taira K
    Oligonucleotides; 2003; 13(5):335-43. PubMed ID: 15000824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs.
    Li MJ; Bauer G; Michienzi A; Yee JK; Lee NS; Kim J; Li S; Castanotto D; Zaia J; Rossi JJ
    Mol Ther; 2003 Aug; 8(2):196-206. PubMed ID: 12907142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, characterization and testing of tRNA3Lys-based hammerhead ribozymes.
    Medina MF; Joshi S
    Nucleic Acids Res; 1999 Apr; 27(7):1698-708. PubMed ID: 10076002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of ribozymes expressed using U1 and T7 vectors for the intracellular cleavage of ANF mRNA.
    De Young MB; Kincade-Denker J; Boehm CA; Riek RP; Mamone JA; McSwiggen JA; Graham RM
    Biochemistry; 1994 Oct; 33(40):12127-38. PubMed ID: 7918434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yeast expression vectors using RNA polymerase III promoters.
    Good PD; Engelke DR
    Gene; 1994 Dec; 151(1-2):209-14. PubMed ID: 7828876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcripts containing a small anti-HIV hammerhead ribozyme that are active in the cell cytoplasm but inactive in vitro as free RNAs.
    Domi A; Beaud G; Favre A
    Biochimie; 1996; 78(7):654-62. PubMed ID: 8955908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of HIV-1 in CEM cells by a potent TAR decoy.
    Lee SW; Gallardo HF; Gaspar O; Smith C; Gilboa E
    Gene Ther; 1995 Aug; 2(6):377-84. PubMed ID: 7584112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective ribozyme delivery in plant cells.
    Perriman R; Bruening G; Dennis ES; Peacock WJ
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):6175-9. PubMed ID: 7597097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transport of intracellularly active ribozymes to the cytoplasm.
    Miyagishi M; Kuwabara T; Taira K
    Cancer Chemother Pharmacol; 2001 Aug; 48 Suppl 1():S96-101. PubMed ID: 11587376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of a high activity c-erbB-2 ribozyme using a fusion gene of c-erbB-2 and the enhanced green fluorescent protein.
    Wiechen K; Zimmer C; Dietel M
    Cancer Gene Ther; 1998; 5(1):45-51. PubMed ID: 9476966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced expression and HIV-1 inhibition of chimeric tRNA(Lys3)-ribozymes under dual U6 snRNA and tRNA promoters.
    Chang Z; Westaway S; Li S; Zaia JA; Rossi JJ; Scherer LJ
    Mol Ther; 2002 Oct; 6(4):481-9. PubMed ID: 12377189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.